Naloxone & Alternative Opioid Antagonists - Buffer Stock Storage & Management

Concepts

• pharmaceutical products
• opioids
• naloxone
• management
• buffer stock
• opioid antagonists - buffer stock storage
• naloxone & alternative opioid antagonists - buffer stock storage & management
• an opioid overdose
• stock
• antagonists

Location

Description

DHSC is conducting a market engagement exercise to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of naloxone and of other drugs that can reverse the effect of an opioid overdose or of drugs taken with opioids. The outcome of the market engagement will inform decisions around potential future procurement and storage of buffer stock as well as providing information on how the market could meet a potential increase in demand across the UK. For avoidance of doubt this is not a call for competition, the purpose is to seek feedback from the market that may inform the final specification and/or procurement approach to the goods and services.

CPV Codes

• 33600000 - Pharmaceutical products
• 33670000 - Medicinal products for the respiratory system
• 33693300 - Addiction treatment

Indicators

• Contract is suitable for SMEs.

Other Information

20240403 Pre-Market Engagement PIN - Naloxone Alternative Opioid Antagonists V1.0 20240403 Pre-Market Engagement PIN - Naloxone Alternative Opioid Antagonists V1.0.docx 20240403 Market Engagement Brief - Naloxone Alternative Opioid Antagonists V1.0 20240403 Market Engagement Brief - Naloxone Alternative Opioid Antagonists V1.0.pdf